Scynexis (SCYX) Depreciation & Amortization (CF) (2013 - 2023)

Scynexis (SCYX) reported Depreciation & Amortization (CF) of $129000.0 for Q4 2023, down 16.77% on a YoY basis from $155000.0 in Q4 2022, and down 12.24% quarter-over-quarter from $147000.0 in Q3 2023.

Scynexis (SCYX) Depreciation & Amortization (CF) (2013 - 2023) Analysis & Trends

Scynexis has reported Depreciation & Amortization (CF) for 11 years, with the latest figure at $129000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Depreciation & Amortization (CF) fell 16.77% year-over-year to $129000.0; the trailing twelve-month figure through Sep 2024 stood at $129000.0 (down 78.71% YoY), and the FY2023 full-year result was $580000.0, down 4.29% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2023 stood at $129000.0, down from $147000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $246000.0 in Q4 2021, with the low at $26000.0 in Q3 2019.
  • Historically, Depreciation & Amortization (CF) has averaged $93800.0 across 5 years, with a median of $88000.0 in 2020.
  • Annual changes were most pronounced in 2019 — Depreciation & Amortization (CF) soared 2900.0% — and 2022, when it sank 36.99%.
  • Scynexis' Depreciation & Amortization (CF) stood at $26000.0 in 2019, then soared by 353.85% to $118000.0 in 2020, then surged by 108.47% to $246000.0 in 2021, then sank by 36.99% to $155000.0 in 2022, then slipped by 16.77% to $129000.0 in 2023.
  • The last three Depreciation & Amortization (CF) figures came in at $129000.0 (Q4 2023), $147000.0 (Q3 2023), and $153000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 239.00 Mn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 22.60 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 7.20 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 19.43 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 22.68 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 497,000.00
10 Scynexis 221.66 Mn 162.40 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 129,000.00
Dec 31, 2023 129,000.00
Sep 30, 2023 147,000.00
Sep 30, 2023 147,000.00
Jun 30, 2023 153,000.00
Jun 30, 2023 153,000.00
Mar 31, 2023 151,000.00
Mar 31, 2023 151,000.00
Dec 31, 2022 155,000.00
Dec 31, 2022 155,000.00
Sep 30, 2022 150,000.00
Sep 30, 2022 150,000.00
Jun 30, 2022 146,000.00
Jun 30, 2022 146,000.00
Mar 31, 2022 155,000.00
Mar 31, 2022 155,000.00
Dec 31, 2021 246,000.00
Dec 31, 2021 246,000.00
Sep 30, 2021 48,000.00
Sep 30, 2021 48,000.00